Chlamydia pneumoniae, Herpes simplex virus and Cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability?

Vasa - Journal of Vascular Diseases

Volumn 34, Issue 3, 2005, Pages 163-169

  Müller, Barbara Theresia ^a,b   Huber, R ^a   Henrich, B ^a   Adams, O ^a   Berns, G ^a   Siebler, M ^a   Jander, S ^a   Muller W ^a   Loncar, R ^a   Godehardt, E ^a   Sandmann, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Chlamydia pneumoniae; Cytomegalovirus; Herpes simplex virus; Plaque destabilization

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; CAROTID ENDARTERECTOMY; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CYTOMEGALOVIRUS; HERPES SIMPLEX VIRUS; HUMAN; INTERNAL CAROTID ARTERY OCCLUSION; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; THROMBOEMBOLISM;

CAROTID STENOSIS; CAUSALITY; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; GERMANY; HERPES SIMPLEX; HUMANS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STATISTICS;

EID: 24344453016     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526.34.3.163     Document Type: Article

References (36)

1. Adam E, Probstfield JL, Burek J, McCollum CH, Melnick JL, Petrie BL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2 (8554): 291-3.
2. Bassiouny HS, Sakaguchi Y, Mikucki SA, McKinsey JF, Piano G, Gewert BL, et al. Juxtalumenal location of plaque necrosis and neoformation in symptomatic stenosis. J Vasc Surg 1997; 26: 585-4.
3. Benditt EP, Barrett T, McDouglas JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA 1983; 80: 6386-9.
4. Cercek B, Shah PK, Noc M, Zahgar D, Zeymer U, Matetzky S, et al. AZACS Investigators. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in acute coronary syndrome (AZACS) trial: a randomised controlled trial. Lancet 2003; 361: 809-1.
5. Chiu BM, Viira E, Tucker W, Fong IW. Chlamydia pneumonia. Cytomegalovirus, and Herpes simplex Virus in atherosclerosis in the carotid artery. Circulation 1997; 96: 2144-8.
6. Coletta A, Thackray S, Nikitin N, Cleland JG. Clinical trials update: highlights of the scientific sessions of The MIRACLE-ICD, OVERTURE; OCTAVE, ABLE1&2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL. Eur J Heart Fail 2002; 4: 381-8.
7. Elkind MSV, Lin IF, Grayston JT, Sacco RL. Chlamydia pneumoniae and the risk of first ischemic stroke. Stroke 2000; 31: 1521-5.
8. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, et al. Impact of infectious burden on progression of carotid atherosclerosis. Stroke 2002; 33: 2581-6.
9. Everett KD, Bush RM, Andersen AA. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int J Syst Bacteriol 1999; 2: 415-40.
10. Gibbs RGJ, Sian M, Mitchell AWM, Greenhalgh RM, Davies AH, et al. Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis. Stroke 2000; 31: 2930-5.
11. Grayston JT, Mordhorst C, Bruu AL, Vene S, Wang SP. Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983. J Infect Dis 1989; 159: 1111-4.
12. Grayston JT, Kuo CC, Coulson AS, Campbell LA, Lawrence RD, Lee MJ, et al. S. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation 1995; 92: 3397-400.
13. Jackson LA, Campbell LA, Schmidt RA, Kuo C, Capuccio AL, Lee MJ, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma. J Infect Dis 2000; 181 Suppl 3: S447-8.
14. Kuo CC, Coulson AS, Campbell LA, Capuccio AL, Lawrence RD, Wang SP, et al. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 1997; 26: 29-31.
15. LaBiche R, Koziol D, Quinn TC, Gydos C, Azhar S, Kewtron G, et al. TJ. Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke 2001; 32: 855-60.
16. Maass M, Krause E, Engel PM, Krüger S. Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis. Angiology 1997; 48: 699-706.
17. Maass M, Bartels C, Krüger S, Krause E, Engel PM, Dalhoff K. Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease. Atherosclerosis 1998; 140 suppl. 1: S25-30.
18. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomen in coronary artery disease. JACC 1998; 31: 827-32.
19. Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 1999; 100: 832-7.
20. Melnick JL, Dreesman GR, McCollum CH, Petrie BL, Burek J, DeBakey ME. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 1983; 2 (8351): 644-7.
21. Neumann FJ. Chlamydia pneumonia-atherosclerosis link. A sound concept in search for clinical relevance. Circulation 2002; 106: 2414-6.
22. Nieto FJ, Adam E, Sorlie P, Farzadegan H, Melnick JL, Cromstock GW, et al. Cohort Study of Cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996; 94: 922-7.
23. O'Connor CM, Dunne MW, Pfeffer MA, Muhlestein JB, Yao L, Gupta S, et al. Investigators in the WIZARDStudy. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 2003; 290: 1515-6.
24. Ong G, Thomas BJ, Mansfield AO, Davidson BR, Taylor Robinson D. Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications. J Clin Pathol 1996; 49: 102-6.
25. Park AE, McCarthy WJ, Pearce WH, Matsumura JS, Yao ST. Carotid plaque morphology correlates with presenting symptomatology. J Vasc Surg 1998; 27: 872-9.
26. Saetta A, Fanourakis G, Agapitos E, Davaris PS. Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation. Cardiovasc Pathol 2000; 9: 181-3.
27. Saikku P, Mattila K, Niemenen MS, Huttunen JK, Leinonen M. Ekman MR, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; 2: 983-5.
28. Sander D, Winsbeck K, Klingelhöfer J, Etgen T, Conrad B. Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity. Circulation 2002; 106: 2428-33.
29. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002; 52: 31-9.
30. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. SAMJ 1992; 82: 158-61.
31. Siscovick DS, Schwartz SM, Corey L, Grayston JT, Ashley R, et al. Chlamydia pneumoniae, Herpes simplex Virus Type 1, and Cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults: The Cardiovascular Health Study. Circulation 2000; 102: 2335-40.
32. Sitzer M, Fürst G, Steinmetz H, Fischer H, Siebler M, Fehlings T, et al. Between-method correlation in quantifying internal carotid stenosis. Stroke 1993; 24: 1513-8.
33. Sorlie PD, Nieto FJ, Adam E, Folsom AR, Shahar E, Massing M. A prospective study of Cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study. Arch Intern Med 2000; 160: 2027-32.
34. Stille W, Dittmann R. Arteriosklerose als Folge einer chronischen Infektion durch Chlamydia pneumoniae. Herz 1998; 23: 185-2.
35. Visser MR, Vercelotti GM. Herpes simplex and atherosclerosis. Eur Heart J 1993; 14 Suppl K: 39-42.
36. Yamashita K, Ouchi K, Gondo T, Nakazawa T, Ito, H. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 1998; 29: 773-8.